12 Best Canadian Stocks With Huge Upside Potential

5. AbCellera Biologics Inc. (NASDAQ:ABCL)

Number of Hedge Fund Holders: 17

Average Upside Potential as of June 20: 90.62%

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best Canadian stocks with huge upside potential. Earlier in May, AbCellera Biologics announced that the US Court of Appeals for the Federal Circuit/CAFC issued a Rule 36 Order, which affirmed the validity of its US Patent No. 10,087,408 (“the ‘408 Patent”). The patent specifically covers microfluidic devices and their application in culturing and selectively recovering cells.

Previously, Bruker Cellular Analysis Inc., which is a subsidiary of Bruker Corporation (NASDAQ:BRKR), had challenged the claims of the ‘408 Patent. Bruker argued for the patent’s invalidity based on allegations of anticipation and obviousness in light of prior art. However, the US Patent Trial and Appeal Board/PTAB rejected all of Bruker’s arguments. The CAFC’s recent decision further confirms the validity of all claims within AbCellera’s ‘408 Patent.

The 408 Patent is an integral part of ongoing multi-patent infringement litigation between AbCellera and Bruker, which is currently pending in the US District Court for the Northern District of California. AbCellera intends to continue defending its intellectual property portfolio and looks forward to proving its infringement case against Bruker in the District Court.

AbCellera Biologics Inc. (NASDAQ:ABCL) discovers and develops antibody-based medicines for indications with unmet medical needs in the US. Bruker Corporation (NASDAQ:BRKR) develops, manufactures, and distributes scientific instruments and analytical and diagnostic solutions.